Diversity, Equity and Inclusion - CLICK HERE

WE ARE

OREGON BIO

Oregon Bio is cultivating conversations with sponsors, members and peers about how diversity and innovation can walk hand-in-hand here in our community. We are learning how systemic bias can negatively impact the advancement of scientific knowledge. We believe we can overcome our differences and disparities by enlarging the opportunities available, and that the bioscience and medtech sectors have important roles to play.

BECOME A MEMBER

WEEKLY NEWSLETTER SIGN UP

BIOSCIENCE IN THE NEWS

What's in a bio-imaging lab? You need to know about the advanced, local tech now available to support the burgeoning regenerative med and biotech sectors. Learn more tomorrow at 9:15 a.m. PDT with @NikonUSA. Reg here: oregonbio.org/event-class/in… #biotech #imaging #letsciencelead

Last week from Oregon Bio Assoc. (it/they)'s Twitter

Are you upskilled for the 'new normal'? Dive into this week's E-newsletter for info on #learning opps. And, get the skinny on tomorrow's Bio Business and Good Beans session about cool, new updates in bio-imaging with #smart pros at @NikonUSA. #prodev conta.cc/31m7x1J

Last week from Oregon Bio Assoc. (it/they)'s Twitter

Health disparities come not only by racism, but also ageism and 'sickism.' Should OR follow OK's lead to stop the use of Quality-Adjusted-Life-Years metrics to say who does - and who doesn't - deserve healthcare? QALY use sets bad precedence. oklahoman.com/article/566341…

Last week from Oregon Bio Assoc. (it/they)'s Twitter

#goodnews #MemberMonday: Local biotech powerhouse @Sediabio is expanding (think: #jobs) and just moved into new 26,667 square feet in @CityofBeaverton. Get the dets here (bit.ly/2PkoZhD) and in this afternoon's E-News blast. pic.twitter.com/bGIxx24A7b

About 2 weeks ago from Oregon Bio Assoc. (it/they)'s Twitter

@VeanaTherap We love this! What are your 15 ideas?

About 2 weeks ago from Oregon Bio Assoc. (it/they)'s Twitter

6/ #live now - Diversity Dialogue - Now it's your turn. The questions: What specific things can legislators and policymakers do to effect positive change to improve DEI? How do we seize the moment? Comments please. #biotech #healthdisparity #equity #culturechange

About 2 weeks ago from Oregon Bio Assoc. (it/they)'s Twitter

5/ #live now: Diversity Dialogue. Quote: "As Lili Gil Valletta has been promoting for many years, we need to incorporate cultural intelligence into all aspects of what we do to adequately address a global community with all its diversity." #diversity #biotech #equity #inclusion

About 2 weeks ago from Oregon Bio Assoc. (it/they)'s Twitter

4/ #live now: Diversity Dialogue- How do we get more BIPOC patients into clinical trials? Great quote from speaker @NateMiles1 of @LillyPad: "Collect less data as that may break down the barriers of trust." #biotech #culturechange #BlackLivesMatter

About 2 weeks ago from Oregon Bio Assoc. (it/they)'s Twitter

3/ #live now-Diversity Dialogue. Speaker Ngondo Khouma of @genentech said: "It's important to have access to the safety net so you can take more chances." #culturechange #biotech #Ignorancediesbyinnovation

About 2 weeks ago from Oregon Bio Assoc. (it/they)'s Twitter

#live now. Diversity Dialogue. Great quote: "That [affirmative action comment] really resonated because [it's] often seen as negative by the majority when in fact we're starting to bring equity and provide help to groups that have historically been disadvantaged." #culturechange

About 2 weeks ago from Oregon Bio Assoc. (it/they)'s Twitter

Sign of things to come at Knight Campus

UO researcher’s work drives launch of spin-off, Penderia Technologies

By Matt Sayre, Contributor, The Register-Guard The Phil and Penny Knight Campus for Accelerating Scientific Impact is not scheduled to open officially until this fall; however, there are early indicators that it could have an outsized local economic impact, as well as a broader scientific one. Once fully staffed, the Knight Campus will be home to about 300 full-time research staff members, […]

Voice of Industry: Sedia 2.x: Scaling up and overcoming challenges, Part 2

Oregon Bio recently caught up with Sedia Biosciences Corp.’s two founders, Roger Gale and Ron Mink, Ph.D. to learn more – not only about how its coping with Covid-19 impacts but more about the company’s innovation strategies. Last week we ran Part 1. Recently, Sedia worked with the City of Beaverton to relocate to expand product manufacturing capabilities to serve an increasing demand for HIV diagnostic and epidemiological assays, specifically HIV recency diagnostics. Although the company […]